Sato S - Search Results

1

Personalised medicine for IPF: getting closer, but not there yet.

Sato S, Kolb MRJ. Sato S, et al. Lancet Respir Med. 2017 Nov;5(11):836-837. doi: 10.1016/S2213-2600(17)30348-X. Epub 2017 Sep 21. Lancet Respir Med. 2017. PMID: 28942087 No abstract available.

2

Lysyl Oxidase-Like 1 Protein Deficiency Protects Mice from Adenoviral Transforming Growth Factor-β1-induced Pulmonary Fibrosis.

Bellaye PS, Shimbori C, Upagupta C, Sato S, Shi W, Gauldie J, Ask K, Kolb M. Bellaye PS, et al. Among authors: sato s. Am J Respir Cell Mol Biol. 2018 Apr;58(4):461-470. doi: 10.1165/rcmb.2017-0252OC. Am J Respir Cell Mol Biol. 2018. PMID: 29115860

3

Synergistic role of HSP90α and HSP90β to promote myofibroblast persistence in lung fibrosis.

Bellaye PS, Shimbori C, Yanagihara T, Carlson DA, Hughes P, Upagupta C, Sato S, Wheildon N, Haystead T, Ask K, Kolb M. Bellaye PS, et al. Among authors: sato s. Eur Respir J. 2018 Jan 31;51(2):1700386. doi: 10.1183/13993003.00386-2017. Print 2018 Feb. Eur Respir J. 2018. PMID: 29386344 Free article.

4

Macitentan reduces progression of TGF-β1-induced pulmonary fibrosis and pulmonary hypertension.

Bellaye PS, Yanagihara T, Granton E, Sato S, Shimbori C, Upagupta C, Imani J, Hambly N, Ask K, Gauldie J, Iglarz M, Kolb M. Bellaye PS, et al. Among authors: sato s. Eur Respir J. 2018 Aug 30;52(2):1701857. doi: 10.1183/13993003.01857-2017. Print 2018 Aug. Eur Respir J. 2018. PMID: 29976656 Free article.

5

Therapeutic targets and early stage clinical trials for pulmonary fibrosis.

Sato S, Yanagihara T, Kolb MRJ. Sato S, et al. Expert Opin Investig Drugs. 2019 Jan;28(1):19-28. doi: 10.1080/13543784.2019.1554054. Epub 2018 Dec 6. Expert Opin Investig Drugs. 2019. PMID: 30513000 Review.

6

Mechanical stress-induced mast cell degranulation activates TGF-β1 signalling pathway in pulmonary fibrosis.

Shimbori C, Upagupta C, Bellaye PS, Ayaub EA, Sato S, Yanagihara T, Zhou Q, Ognjanovic A, Ask K, Gauldie J, Forsythe P, Kolb MRJ. Shimbori C, et al. Among authors: sato s. Thorax. 2019 May;74(5):455-465. doi: 10.1136/thoraxjnl-2018-211516. Epub 2019 Feb 26. Thorax. 2019. PMID: 30808717

7

Fibrocytes and fibroblasts-Where are we now.

Chong SG, Sato S, Kolb M, Gauldie J. Chong SG, et al. Among authors: sato s. Int J Biochem Cell Biol. 2019 Nov;116:105595. doi: 10.1016/j.biocel.2019.105595. Epub 2019 Aug 29. Int J Biochem Cell Biol. 2019. PMID: 31473260 Review.

8

What have we learned from basic science studies on idiopathic pulmonary fibrosis?

Yanagihara T, Sato S, Upagupta C, Kolb M. Yanagihara T, et al. Among authors: sato s. Eur Respir Rev. 2019 Sep 11;28(153):190029. doi: 10.1183/16000617.0029-2019. Print 2019 Sep 30. Eur Respir Rev. 2019. PMID: 31511255 Free PMC article. Review.

9

Fibrotic extracellular matrix induces release of extracellular vesicles with pro-fibrotic miRNA from fibrocytes.

Sato S, Chong SG, Upagupta C, Yanagihara T, Saito T, Shimbori C, Bellaye PS, Nishioka Y, Kolb MR. Sato S, et al. Thorax. 2021 Sep;76(9):895-906. doi: 10.1136/thoraxjnl-2020-215962. Epub 2021 Apr 15. Thorax. 2021. PMID: 33859055

10

Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.

Yanagihara T, Tsubouchi K, Zhou Q, Chong M, Otsubo K, Isshiki T, Schupp JC, Sato S, Scallan C, Upagupta C, Revill S, Ayoub A, Chong SG, Dvorkin-Gheva A, Kaminski N, Tikkanen J, Keshavjee S, Paré G, Guignabert C, Ask K, Kolb MRJ. Yanagihara T, et al. Among authors: sato s. Am J Respir Crit Care Med. 2023 Jun 1;207(11):1498-1514. doi: 10.1164/rccm.202109-2174OC. Am J Respir Crit Care Med. 2023. PMID: 36917778

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,234 results

Search Page

Filters